GLOW-FDG: Generalized cancer LesiOn Whole-body segmentation model for $^{18}$F-FDG-PET/CT

• URL: http://arxiv.org/abs/2607.03931v1
• Date: Sat, 04 Jul 2026 15:51:28 GMT
• Title: GLOW-FDG: Generalized cancer LesiOn Whole-body segmentation model for $^{18}$F-FDG-PET/CT
• Abstract summary: Whole-body fluorodeoxyglucose positron emission tomography combined with computed tomography is widely used in cancer care, but manual lesion delineation is slow, subjective, and difficult to scale.<n>We present GLOW-FDG, an open-source artificial intelligence model for whole-body cancer lesion segmentation in fluorodeoxyglucose positron emission tomography and computed tomography.<n>Across breast cancer, nonmetastatic and oligometastatic lung cancer, head and neck cancer, and metastatic melanoma, GLOW-FDG consistently outperformed publicly available benchmark models in lesion detection.
• Score: 2.2362259345352693
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Whole-body fluorodeoxyglucose positron emission tomography combined with computed tomography is widely used in cancer care, but manual lesion delineation is slow, subjective, and difficult to scale. We present GLOW-FDG, an open-source artificial intelligence model for whole-body cancer lesion segmentation in fluorodeoxyglucose positron emission tomography and computed tomography. The model was trained on 1,563 scans spanning multiple cancer types and evaluated on 185 external scans from independent institutions. Across breast cancer, nonmetastatic and oligometastatic lung cancer, head and neck cancer, and metastatic melanoma, GLOW-FDG consistently outperformed publicly available benchmark models in lesion detection, while reducing false positives and maintaining strong segmentation accuracy. Quantification of total tumor burden and total lesion glycolysis was robust across cohorts, and performance approached the variability observed between expert radiation oncologists. These results support GLOW-FDG as a generalizable tool for automated cancer segmentation and quantitative imaging biomarker extraction in whole-body imaging.

Related papers

• Dual-Modal Lung Cancer AI: Interpretable Radiology and Microscopy with Clinical Risk Integration [0.0]
  This study proposes a dual-modal artificial intelligence framework that integrates CT radiology with hematoxylin and eosin histopathology for lung cancer diagnosis and subtype classification.<n>The system employs convolutional neural networks to extract radiologic and histopathologic features and incorporates clinical metadata to improve robustness.<n> Experimental results show strong performance with accuracy up to 0.87, AUROC above 0.97, and macro F1-score of 0.88.
  arXiv  Detail & Related papers  (2026-04-17T14:37:54Z)
• A Lightweight Multi-Cancer Tumor Localization Framework for Deployable Digital Pathology [0.46843765915430247]
  Deep learning-based tumor detection trained within specific cancers may exhibit reduced robustness when applied across different tumor types.<n>A multi-cancer tumor localization model (MuCTaL) was trained on 79,984 non-overlapping tiles from four cancers.<n>The model achieved a tile-level ROC-AUC of 0.97 in validation data from the four training cancers, and 0.71 on an independent ductal adenocarcinoma cohort.
  arXiv  Detail & Related papers  (2026-03-09T19:00:04Z)
• Hide-and-Seek Attribution: Weakly Supervised Segmentation of Vertebral Metastases in CT [68.09387763135236]
  We introduce a weakly supervised method trained solely on vertebra-level healthy/malignant labels, without any lesion masks.<n>We achieve strong blastic/lytic performance despite no mask supervision.
  arXiv  Detail & Related papers  (2025-12-07T14:03:28Z)
• Scaling Artificial Intelligence for Multi-Tumor Early Detection with More Reports, Fewer Masks [59.37427210144734]
  We introduce R-Super, which trains AI to segment tumors that match descriptions in medical reports.<n>When trained on 101,654 reports, AI models achieved performance comparable to those trained on 723 masks.<n>R-Super enabled segmentation of tumors in the spleen, gallbladder, prostate, bladder, uterus, and esophagus.
  arXiv  Detail & Related papers  (2025-10-16T15:35:44Z)
• Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types [0.5986174494948199]
  The model was developed using over 20 000 whole-slide images from over 4 000 patients with colorectal, endometrial, lung, or prostate carcinoma.<n>No loss of performance was observed when comparing the universal model with models specialised on single cancer types.
  arXiv  Detail & Related papers  (2025-10-13T09:18:15Z)
• Breast Cancer Classification in Deep Ultraviolet Fluorescence Images Using a Patch-Level Vision Transformer Framework [6.0791593833288085]
  A deep ultraviolet fluorescence scanning microscope (DUV-FSM) enables rapid acquisition of whole surface images (WSIs) for excised tissue.<n>This study introduces a DUV WSI classification framework using a patch-level vision transformer (ViT) model, capturing local and global features.<n>A comprehensive 5-fold cross-validation demonstrates the proposed approach significantly outperforms conventional deep learning methods, achieving a classification accuracy of 98.33%.
  arXiv  Detail & Related papers  (2025-05-12T15:22:54Z)
• Optimizing Synthetic Correlated Diffusion Imaging for Breast Cancer Tumour Delineation [71.91773485443125]
  We show that the best AUC is achieved by the CDI$s$ - optimized modality, outperforming the best gold-standard modality by 0.0044. Notably, the optimized CDI$s$ modality also achieves AUC values over 0.02 higher than the Unoptimized CDI$s$ value.
  arXiv  Detail & Related papers  (2024-05-13T16:07:58Z)
• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Towards Generalizable Tumor Synthesis [48.45704270448412]
  Tumor synthesis enables the creation of artificial tumors in medical images, facilitating the training of AI models for tumor detection and segmentation. This paper made a progressive stride toward generalizable tumor synthesis by leveraging a critical observation. We have ascertained that generative AI models, e.g., Diffusion Models, can create realistic tumors generalized to a range of organs even when trained on a limited number of tumor examples from only one organ.
  arXiv  Detail & Related papers  (2024-02-29T18:57:39Z)
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging [59.79875531898648]
  DeepGlioma is an artificial-intelligence-based diagnostic screening system. DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy.
  arXiv  Detail & Related papers  (2023-03-23T18:50:18Z)
• Spectral-Spatial Recurrent-Convolutional Networks for In-Vivo Hyperspectral Tumor Type Classification [49.32653090178743]
  We demonstrate the feasibility of in-vivo tumor type classification using hyperspectral imaging and deep learning. Our best model achieves an AUC of 76.3%, significantly outperforming previous conventional and deep learning methods.
  arXiv  Detail & Related papers  (2020-07-02T12:00:53Z)
• Synthesizing lesions using contextual GANs improves breast cancer classification on mammograms [0.4297070083645048]
  We present a novel generative adversarial network (GAN) model for data augmentation that can realistically synthesize and remove lesions on mammograms. With self-attention and semi-supervised learning components, the U-net-based architecture can generate high resolution (256x256px) outputs.
  arXiv  Detail & Related papers  (2020-05-29T21:23:00Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.